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SWALLOWING FEATURES IN HUNTINGTON’S DISEASE
A comparison between safe versus unsafe swallowing
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Patients were consecutively recruited between April 2016 and July
2017 during their first or follow-up neurological visit. Inclusion criteria
were: clinical diagnosis of HD with familiarity and/or genetic
confirmation, no enteral feeding, ability to express their informed
consent. Patients with comorbidity with other neurological diseases,
history of head neck cancer, self-reported or documented dysphagia
prior to HD diagnosis were excluded.
Overall, 24 patients (10 males and 14 females) were included. Mean
age at the time of the assessment was 60±12.3 (39-79), mean age at
disease onset was 51.8 ±18.4 (32-76), mean disease duration was 8.3
±4.3 years (3-20). All patients underwent a neurological assessment
and an instrumental and clinical evaluation of swallowing.
CLINICAL ASSESSMENT
➢Unified Huntington’s Disease Rating Scale (UHDRS) 
Fiberoptic endoscopic evaluation of swallowing:
➢ 5-10-20 ml blue dyed water and pudding x 3
➢ ½ cracker x 3
➢ Penetration-aspiration scale (PAS) and Yale pharyngeal residue 
severity rating scale (YPRSRS)
➢Mann Assessment Swallowing Assessment (MASA)
➢Test of Masticating and Swallowing Solids (TOMASS)
➢Functional oral intake scale (FOIS)
➢Huntington’s disease dysphagia scale (HDDS)
➢Mealtime assessment scale (MAS)
INSTRUMENTAL ASSESSMENT
NEUROLOGICAL ASSESSMENT
Patients with a PAS score ≥2 with at least one consistency were
considered unsafe swallowers, while patients with a YPRSRS score ≥3
with at least one consistency were considered inefficient swallowers.
Mann-Whitney test was used to compare deglutition variables between
safe and unsafe swallowers.
This study attempt to improve knowledge on dysphagia in HD. In
particular, it aims to:
1. Identify pharyngeal swallowing profiles in HD
2. Compare neurological and swallowing features in safe 
versus unsafe swallowers
Huntington’s Disease (HD) is a neurodegenerative disorder caused by a
CAG repeated expansion in the mutated HD gene on chromosome
4p16.3, which encodes the mutated protein huntingtin. Dysphagia has
been reported in around 72-100% of patients with HD already in the
early stage [1-2] and aspiration pneumonia is the main cause of death
in this population [3]. Despite its high prevalence, at the present time
only few studies have investigated dysphagia in HD. Moreover, many of
these studies are limited to single case reports and did not include an
instrumental assessment of swallowing nor a meticulous assessment of
oral preparatory stage [4]. Hence, little is known regarding swallowing
features of this population.
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Based on FEES analysis, 11 patients were considered safe swallowers
and 13 patients unsafe swallowers. Swallowing efficacy was preserved
in 7 patients, while a YPRSRS ≥3 was assigned 17 patients with at least
one consistency. Prevalence of pharyngeal swallowing profiles is shown
in the graph below.
When comparing safe versus unsafe swallowers, the two groups were
comparable for age (p=0.424) and duration of the disease (p=0.089).
Fig 1: HD’s pharyngeal swallowing profiles
A statistical significant
difference was found for the
scores of the UHDRS I subscale,
assessing motor function
(p=0.028).
Fig 2: UHDRS I in safe vs unsafe swallowers
Fig 3: YPRSRS in 
valleculae with solids
in safe vs unsafe
swallowers
None of the investigated
swallowing features was
statistically different.
Present data suggest that efficacy is more impaired than safety in HD
patients. Swallowing safety seems to be progressively reduced with
disease progression and decline of motor function. HD patients unsafe
swallowers show comparable pharyngeal residue, efficacy of oral
phase, performance in meal consumption, oral intake and perception
of swallowing impairment to HD safe swallowers. Lack of statistically
significant differences may be due to the small sample size and the low
severity of airway invasion in our unsafe swallowers group.
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